Monoclonal antibody against tfpi and use thereof
AssigneeAmpsource Biopharma Shanghai Inc.
InventorsQiang LI, Cui WU, Zhao DONG, Li ZHOU, Chi ZHOU
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmpsource Biopharma Shanghai Inc.
InventorsQiang LI, Cui WU, Zhao DONG, Li ZHOU, Chi ZHOU
Estimating the term…
Antibodies or antigen-binding fragments thereof against human TFPI are provided, along with nucleic acid molecules encoding said antibodies, expression vectors and host cells for expressing said antibodies, and methods for producing said antibodies. Furthermore, pharmaceutical compositions containing the antibody or the antigen-binding fragment thereof are provided, as well as their use in the manufacture of a medicament for the prevention and/or treatment of coagulation disorders in patients with genetic or acquired coagulation factor deficiencies.
An antibody or an antigen-binding fragment thereof capable of specifically binding to TFPI, wherein the heavy chain variable region (VH) of the antibody or the antigen-binding fragment thereof comprises at least one, two, or three complementarity-determining regions (CDRs) selected from the group consisting of:
Dependencies are inferred from the claim text.